| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.3 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |